The Department has made no assessment of the role played, if any, by the Wuhan Institute of Virology in the spread of COVID-19.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"} } , "answeringMemberPrinted" : {"_value" : "Lord Bethell"} , "dateOfAnswer" : {"_value" : "2020-05-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-05-20T15:56:47.72Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-04-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Wuhan Institute of Virology: Coronavirus"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what assessment they have made of the role played, if any, by the Wuhan Institute of Virology in the spread of COVID-19. [T]", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/883", "label" : {"_value" : "Biography information for Lord Jopling"} } , "tablingMemberPrinted" : [{"_value" : "Lord Jopling"} ], "uin" : "HL3402"} , {"_about" : "http://data.parliament.uk/resources/1091610", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1091610/answer", "answerText" : {"_value" : "
The Department has made no recent estimate of the value of drugs supplied by the National Health Service, which are returned unopened or unsealed and subsequently destroyed due to the death of a recipient or another reason that made their use unnecessary.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"} } , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"} , "dateOfAnswer" : {"_value" : "2019-04-01", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-04-01T11:07:20.3Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-03-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Drugs"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what estimate they have made of the value of drugs supplied by the NHS which are returned unopened or unsealed and subsequently destroyed due to (1) the death of the recipient, and (2) others reasons that made the use of them unnecessary.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/883", "label" : {"_value" : "Biography information for Lord Jopling"} } , "tablingMemberPrinted" : [{"_value" : "Lord Jopling"} ], "uin" : "HL14656"} , {"_about" : "http://data.parliament.uk/resources/1091611", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1091611/answer", "answerText" : {"_value" : "
The Department is concerned about wastage from unused medicines and is keen to minimise unnecessary extra costs. However, it does not promote the reuse of returned medicines that have left a pharmacy and returned unused by patients. This is because it is not possible to guarantee the quality of returned medicines on physical inspection alone. When medicines are returned from patient\u2019s homes, there is no way of knowing whether the medicines have been stored or handled appropriately. Some medicines may deteriorate if, for example, left too close to a radiator, in direct sunlight or exposed to the environment. This applies whether the medicines are unopened or unsealed.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"} } , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"} , "dateOfAnswer" : {"_value" : "2019-04-01", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-04-01T11:07:04.43Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-03-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Drugs"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government whether, and if so why, drugs supplied by the NHS which are returned unopened or unsealed owing to circumstances which make them no longer required are destroyed.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/883", "label" : {"_value" : "Biography information for Lord Jopling"} } , "tablingMemberPrinted" : [{"_value" : "Lord Jopling"} ], "uin" : "HL14657"} , {"_about" : "http://data.parliament.uk/resources/980151", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/980151/answer", "answerText" : {"_value" : "
<\/strong><\/p> There are no active vaccination programmes against smallpox or anthrax for any of the emergency services.<\/p> Vaccines can be made available to first responders responding to a confirmed anthrax incident if required. The Government still holds the smallpox vaccine for use against certain strains of orthopox viruses if required.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"}
}
, "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"}
, "dateOfAnswer" : {"_value" : "2018-10-15", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-10-15T10:54:32.86Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-10-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Vaccination: Emergency Services"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty's Government how many members of each of the emergency services have been vaccinated against (1) smallpox, and (2) anthrax; what percentage of the total staff of each service this represents; and of those vaccinated, how many will need to be vaccinated again in the next year.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/883", "label" : {"_value" : "Biography information for Lord Jopling"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Jopling"}
], "uin" : "HL10420"}
, {"_about" : "http://data.parliament.uk/resources/980152", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/980152/answer", "answerText" : {"_value" : " The Government has not undertaken or commissioned research in this area. However, the National Institute for Health Research and the Medical Research Council both have a wide portfolio of research activity in vaccines which support underpinning vaccine research and new vaccine technologies, through to clinical trials.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"}
}
, "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"}
, "dateOfAnswer" : {"_value" : "2018-10-15", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-10-15T10:56:26.073Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-10-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Horsepox: Vaccination"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty's Government what research they have undertaken or commissioned into the creation of an effective vaccine against the synthetic horsepox virus.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/883", "label" : {"_value" : "Biography information for Lord Jopling"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Jopling"}
], "uin" : "HL10421"}
, {"_about" : "http://data.parliament.uk/resources/980153", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/980153/answer", "answerText" : {"_value" : " Clostridium botulinum toxin is the active substance used as a starting material for the manufacture of Botox, a licensed human medicine. Active substances are those substances which give a medicinal product its therapeutic effect and must be manufactured to Good Manufacturing Practice standards for active substances used as a starting material.<\/p> From 20 August 2013, manufacturers, importers and distributors of active substances who are established in the United Kingdom had to register their activity with the Medicines and Healthcare products Regulatory Agency.<\/p> The UK has no registered importers of the active substance Clostridium botulinum toxin, but has one registered manufacturer of the toxin that is Good Manufacturing Practice compliant, and was last inspected in May 2016.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"}
}
, "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"}
, "dateOfAnswer" : {"_value" : "2018-10-15", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-10-15T10:57:06.623Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-10-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Botulinum Toxin: Imports"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty's Government how many import licences or permissions were granted in each of the last five years for live botulin toxins for the manufacture of Botox.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/883", "label" : {"_value" : "Biography information for Lord Jopling"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Jopling"}
], "uin" : "HL10422"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 6, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}